Effect of radioprotectant WR 2721 on cyclic nucleotides, prostaglandins, and lysosomes.
Within 1 hr after ip injection of the radioprotectant WR 2721 into rats, splenic cGMP levels dropped and remained suppressed for 6 hr before returning to normal. However, if rats were exposed to ionizing radiation 30-40 min after WR 2721 treatment, they had higher cGMP levels at 3 hr postirradiation than the nonirradiated, drug-treated controls, but the cGMP content was still found to be lower than that of the irradiated nondrug-treated controls. Radiation exposure of animals pretreated with WR 2721 also resulted in higher liver and spleen levels of cAMP and additional elevations in spleen prostaglandin content, compared with irradiated controls at 3-6 hr after radiation treatment. The secondary fluctuations of lysosomal enzyme activities, prostaglandin content, and cyclic nucleotide levels were also altered in irradiated rats pretreated with WR 2721 when compared with irradiated controls. Liver and spleen lysosomal beta-glucuronidase activities, spleen cAMP and cGMP levels, and spleen prostaglandin concentrations were closer to physiological levels at 3 days postirradiation in rats given WR 2721 before the radiation treatment.
D004999:Amifostine / Q000494:pharmacology*; D000818:Animals; D000242:Cyclic AMP / Q000032:analysis; D006152:Cyclic GMP / Q000032:analysis; D005966:Glucuronidase / Q000032:analysis; D007425:Intracellular Membranes / Q000187:drug effects; D008099:Liver / Q000378:metabolism; D008247:Lysosomes / Q000201:enzymology*; D008297:Male; D009712:Nucleotides, Cyclic / Q000378:metabolism*; D009946:Organothiophosphorus Compounds / Q000494:pharmacology*; D011453:Prostaglandins / Q000378:metabolism*; D051381:Rats; D011919:Rats, Inbred Strains; D013154:Spleen / Q000378:metabolism; D013997:Time Factors; D014916:Whole-Body Irradiation
D009712:Nucleotides, Cyclic; D009946:Organothiophosphorus Compounds; D011453:Prostaglandins; D000242:Cyclic AMP; D005966:Glucuronidase; D006152:Cyclic GMP; D004999:Amifostine